HK1256104A1 - 作為對象的細胞外容量狀態的標誌物的mr-proadm - Google Patents
作為對象的細胞外容量狀態的標誌物的mr-proadmInfo
- Publication number
- HK1256104A1 HK1256104A1 HK18115179.1A HK18115179A HK1256104A1 HK 1256104 A1 HK1256104 A1 HK 1256104A1 HK 18115179 A HK18115179 A HK 18115179A HK 1256104 A1 HK1256104 A1 HK 1256104A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- proadm
- marker
- subject
- volume status
- extracellular volume
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15196754 | 2015-11-27 | ||
PCT/EP2016/078702 WO2017089474A1 (en) | 2015-11-27 | 2016-11-24 | MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1256104A1 true HK1256104A1 (zh) | 2019-09-13 |
Family
ID=54780102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18115179.1A HK1256104A1 (zh) | 2015-11-27 | 2018-11-27 | 作為對象的細胞外容量狀態的標誌物的mr-proadm |
Country Status (8)
Country | Link |
---|---|
US (1) | US20180348235A1 (zh) |
EP (1) | EP3380845A1 (zh) |
JP (1) | JP6944449B2 (zh) |
CN (1) | CN108291918A (zh) |
BR (1) | BR112018010269A2 (zh) |
CA (1) | CA3006390A1 (zh) |
HK (1) | HK1256104A1 (zh) |
WO (1) | WO2017089474A1 (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019018545A1 (en) | 2017-07-18 | 2019-01-24 | The Research Foundation For The State University Of New York | BIOMARKERS OF INTRACRANIAL ANEVISM |
EP3438668A1 (en) | 2017-08-04 | 2019-02-06 | B.R.A.H.M.S GmbH | Diagnosis and risk stratification of fungal infections |
JP7291688B2 (ja) * | 2017-09-13 | 2023-06-15 | ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 重篤患者における腎置換療法のための指標としてのアドレノメズリン前駆体 |
CA3075440A1 (en) * | 2017-09-13 | 2019-03-21 | B.R.A.H.M.S Gmbh | Pro-adm as a therapy monitoring marker for critcally ill patients |
EP3502691A1 (en) * | 2017-12-20 | 2019-06-26 | B.R.A.H.M.S GmbH | Proadrenomedullin as indicator for renal replacement therapy in critically ill patients |
ES2909399T3 (es) | 2017-09-13 | 2022-05-06 | Brahms Gmbh | Proadrenomedulina como marcador de niveles anormales de plaquetas |
EP3729083A1 (en) * | 2017-12-20 | 2020-10-28 | B.R.A.H.M.S GmbH | Antibiotic therapy guidance based on pro-adm |
EP3578989A1 (en) * | 2018-06-06 | 2019-12-11 | B.R.A.H.M.S GmbH | Pro-adm for prognosis of trauma-related complications in polytrauma patients |
WO2020017013A1 (ja) * | 2018-07-19 | 2020-01-23 | Posh Wellness Laboratory株式会社 | 検出装置、シートベルト、及び運転手監視システム |
EP3608673A1 (en) * | 2018-08-08 | 2020-02-12 | B.R.A.H.M.S GmbH | Pro-adm for prognosing the risk of a medical condition requiring hospitalization in patients with symptoms of infectious disease |
US10971255B2 (en) * | 2018-09-14 | 2021-04-06 | Zasti Inc. | Multimodal learning framework for analysis of clinical trials |
US11101043B2 (en) | 2018-09-24 | 2021-08-24 | Zasti Inc. | Hybrid analysis framework for prediction of outcomes in clinical trials |
US20230184786A1 (en) * | 2020-03-20 | 2023-06-15 | FORSYTH DENTAL INFIRMARY FOR CHILDREN, d/b/a THE FORSYTH INSTITUTE | Methods of Detecting and Treating Immune Responses Associated with Viral Infection |
KR102544219B1 (ko) * | 2021-08-17 | 2023-06-14 | 한림대학교 산학협력단 | 코펩틴의 농도를 이용한 외상성 뇌 손상의 진단 방법 |
CN114612799B (zh) * | 2022-03-11 | 2022-09-16 | 应急管理部国家自然灾害防治研究院 | 基于滑坡/非滑坡面积比的空间自适应正负样本生成方法及系统 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2570703B1 (fr) | 1984-09-26 | 1988-07-08 | Commissariat Energie Atomique | Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents |
US4882733A (en) | 1987-03-13 | 1989-11-21 | Ford Aerospace Corporation | Method and apparatus for combining encoding and modulation |
FR2664699B1 (fr) | 1990-07-13 | 1995-08-18 | Cis Bio Int | Procede d'amplification du signal d'emission d'un compose luminescent. |
JP2005532394A (ja) * | 2002-07-02 | 2005-10-27 | ガリレオ ファーマシューティカルズ, インコーポレイティド | 雌性被験体における炎症性症状および/またはバイオマーカーの低減のための組成物および方法 |
DE10316583A1 (de) * | 2003-04-10 | 2004-10-28 | B.R.A.H.M.S Aktiengesellschaft | Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung |
US8173596B2 (en) * | 2004-05-14 | 2012-05-08 | The University Of North Carolina At Chapel Hill | Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis |
CN101025414A (zh) * | 2006-02-21 | 2007-08-29 | 郑州市精科分析仪器有限公司 | 一种激光血球计数仪 |
DE102006034142A1 (de) * | 2006-07-24 | 2008-01-31 | B.R.A.H.M.S. Aktiengesellschaft | Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden |
DE102006052916A1 (de) * | 2006-11-08 | 2008-05-15 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM |
US9012151B2 (en) * | 2006-11-09 | 2015-04-21 | B.R.A.H.M.S. Gmbh | Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin |
DE102007022367A1 (de) | 2007-05-07 | 2008-11-20 | B.R.A.H.M.S Ag | Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten |
EP2108958A1 (en) | 2008-04-09 | 2009-10-14 | B.R.A.H.M.S. Aktiengesellschaft | Pro-Endothelin-1 for the prediction of impaired peak oxygen consumption |
EP2180322A1 (en) * | 2008-10-22 | 2010-04-28 | BRAHMS Aktiengesellschaft | Prognostic biomarkers for the progression of primary chronic kidney disease |
US20120003672A1 (en) * | 2008-10-31 | 2012-01-05 | B.R.A.H.M.S Gmbh | In vitro-method for the diagnosis, prognosis, monitoring and therapy follow-up of disorders associated with the metabolic syndrome, a cardiovascular disease and/or insulin resistance |
ES2431358T3 (es) * | 2008-11-11 | 2013-11-26 | B.R.A.H.M.S Gmbh | Pronóstico y evaluación del riesgo en pacientes que padecen insuficiencia cardíaca mediante la determinación de la concentración de ADM |
CN101825627B (zh) * | 2009-03-02 | 2013-10-02 | 江苏迈迪基因生物科技有限公司 | 心力衰竭的生物标志物的联合并行检测方法及诊断试剂盒 |
WO2010128071A1 (en) * | 2009-05-05 | 2010-11-11 | Brahms Ag | Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction |
EP3032261B1 (en) * | 2010-06-18 | 2018-05-23 | B.R.A.H.M.S GmbH | Mr-pro-amd for the prediction of incident cancer in males subject below the age of 57.9 years |
MY174877A (en) * | 2011-11-16 | 2020-05-20 | Adrenomed Ag | Anti-adrenomedullin (adm) antibpdy or anti-adm antibody fragment of anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic of acute disease or acute condition |
KR102176469B1 (ko) * | 2011-11-16 | 2020-11-10 | 아드레노메드 아게 | 요법에 사용하기 위한 항-아드레노메둘린 (adm) 항체 또는 항-adm 항체 단편 또는 항-adm 비-ig 스캐폴드 |
PL2780371T3 (pl) * | 2011-11-16 | 2019-06-28 | Adrenomed Ag | Przeciwciało przeciwko adrenomedulinie (ADM) lub fragment przeciwciała przeciwko ADM lub rusztowanie nie-Ig przeciwko ADM do regulowania równowagi płynów u pacjenta z chorobą przewlekłą lub ostrą |
JP6259905B2 (ja) * | 2013-03-20 | 2018-01-10 | シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング | 血圧降下治療をガイドするアドレノメジュリン |
-
2016
- 2016-11-24 CN CN201680069503.1A patent/CN108291918A/zh active Pending
- 2016-11-24 BR BR112018010269A patent/BR112018010269A2/pt unknown
- 2016-11-24 EP EP16805747.9A patent/EP3380845A1/en active Pending
- 2016-11-24 WO PCT/EP2016/078702 patent/WO2017089474A1/en active Application Filing
- 2016-11-24 CA CA3006390A patent/CA3006390A1/en active Pending
- 2016-11-24 US US15/779,000 patent/US20180348235A1/en active Pending
- 2016-11-24 JP JP2018527070A patent/JP6944449B2/ja active Active
-
2018
- 2018-11-27 HK HK18115179.1A patent/HK1256104A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN108291918A (zh) | 2018-07-17 |
WO2017089474A1 (en) | 2017-06-01 |
CA3006390A1 (en) | 2017-06-01 |
RU2018123169A (ru) | 2019-12-30 |
RU2018123169A3 (zh) | 2020-03-24 |
BR112018010269A2 (pt) | 2019-02-05 |
EP3380845A1 (en) | 2018-10-03 |
JP2019502104A (ja) | 2019-01-24 |
US20180348235A1 (en) | 2018-12-06 |
JP6944449B2 (ja) | 2021-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1256104A1 (zh) | 作為對象的細胞外容量狀態的標誌物的mr-proadm | |
ZA201704561B (en) | Fungicidal compositions | |
IL248991A0 (en) | Converted dihydroisoquinolinone compounds | |
IL247660B (en) | Diaminotriazine compounds as herbicides | |
GB201409044D0 (en) | New compounds | |
HRP20181530T1 (hr) | Novi sulfonilaminobenzamidni spojevi | |
GB201404498D0 (en) | New compounds | |
GB201416444D0 (en) | New compounds | |
GB201417344D0 (en) | New compounds | |
GB201417346D0 (en) | New compounds | |
GB201416430D0 (en) | New compounds | |
GB201400218D0 (en) | A sporicidal composition | |
GB201402647D0 (en) | New compounds |